Design of layer-by-layer lipid-polymer hybrid nanoparticles to elicit oral bioavailability of buspirone hydrochloride

References

• Abasian, P.; Ghanavati, S.; Rahebi, S.; Nouri Khorasani, S.; Khalili, S. Polymeric Nanocarriers in Targeted Drug Delivery Systems: A Review. Polymers for Advanced Techs 2020, 31, 2939–2954. DOI: 10.1002/pat.5031.
   Web of Science ®Google Scholar
• Ghitman, J.; Biru, E. I.; Stan, R.; Iovu, H. Review of Hybrid PLGA Nanoparticles: Future of Smart Drug Delivery and Theranostics Medicine. Mater Des 2020, 193, 108805. DOI: 10.1016/j.matdes.2020.108805.
   Web of Science ®Google Scholar
• Abdel-Bar, H. M.; Abdallah, I. A.; Fayed, M. A. A.; Moatasim, Y.; Mostafa, A.; El-Behairy, M. F.; Elimam, H.; Elshaier, Y. A. M. M.; Abouzid, K. A. M. Lipid Polymer Hybrid Nanocarriers as a Combinatory Platform for Different anti-SARS-CoV-2 Drugs Supported by Computational Studies. RSC Adv 2021, 11, 28876–28891. DOI: 10.1039/D1RA04576H.
   PubMed Web of Science ®Google Scholar
• Mitchell, M. J.; Billingsley, M. M.; Haley, R. M.; Wechsler, M. E.; Peppas, N. A.; Langer, R. Engineering Precision Nanoparticles for Drug Delivery. Nat Rev Drug Discov 2021, 20, 101–124. DOI: 10.1038/s41573-020-0090-8.
   PubMed Web of Science ®Google Scholar
• Mohanty, A.; Uthaman, S.; Park, I.-K. Utilization of Polymer-Lipid Hybrid Nanoparticles for Targeted Anti-Cancer Therapy. Molecules 2020, 25, 4377. DOI: 10.3390/molecules25194377.
   PubMed Web of Science ®Google Scholar
• Yasir, M.; Chauhan, I.; Zafar, A.; Verma, M.; Noorulla, K. M.; Tura, A. J.; Alruwaili, N. K.; Haji, M. J.; Puri, D.; Gobena, W. G.; et al. Buspirone Loaded Solid Lipid Nanoparticles for Amplification of Nose to Brain Efficacy: Formulation Development, Optimization by Box-Behnken Design, in-Vitro Characterization and in-Vivo Biological Evaluation. J Drug Deliv Sci Technol 2021, 61, 102164. DOI: 10.1016/j.jddst.2020.102164.
   Web of Science ®Google Scholar
• Loane, C.; Politis, M. Buspirone: What is It All about? Brain Res 2012, 1461, 111–118. DOI: 10.1016/j.brainres.2012.04.032.
   PubMed Web of Science ®Google Scholar
• Bharti, K.; Mittal, P.; Mishra, B. Formulation and Characterization of Fast Dissolving Oral Films Containing Buspirone Hydrochloride Nanoparticles Using Design of Experiment. J Drug Deliv Sci Technol 2019, 49, 420–432. DOI: 10.1016/j.jddst.2018.12.013.
   Web of Science ®Google Scholar
• Al-Khalili, M.; Meidan, V. M.; Michniak, B. B. Iontophoretic Transdermal Delivery of Buspirone Hydrochloride in Hairless Mouse Skin. AAPS PharmSci 2003, 5, E14–71. DOI: 10.1208/ps050214.
   PubMedGoogle Scholar
• Bari, N. K.; Fazil, M.; Hassan, M. Q.; Haider, M. R.; Gaba, B.; Narang, J. K.; Baboota, S.; Ali, J. Brain Delivery of Buspirone Hydrochloride Chitosan Nanoparticles for the Treatment of General Anxiety Disorder. Int J Biol Macromol 2015, 81, 49–59. DOI: 10.1016/j.ijbiomac.2015.07.041.
   PubMed Web of Science ®Google Scholar
• Abdallah, M. H.; Abdelnabi, D. M.; Elghamry, H. A. Response Surface Methodology for Optimization of Buspirone Hydrochloride-Loaded in Situ Gel for Pediatric Anxiety. Gels 2022, 8, 395. DOI: 10.3390/gels8070395.
   PubMed Web of Science ®Google Scholar
• Rekharani, A. S.; Nidamanuri, B. S. S.; Rajendra, P. K. M.; Venkatachalam, S.; Selvaraj, J.; Natarajan, J. Formulation, Optimization and Characterization of Bupropion Hydrochloride Loaded Nanostructured Lipid Carriers for Intra-Nasal Administration: An Approach to Management of Smoking Cessation. CNANOM 2022, 12, 217–232. DOI: 10.2174/2468187313666221020143555.
   Google Scholar
• Rajput, A.; Pingale, P.; Telange, D.; Chalikwar, S.; Borse, V. Lymphatic Transport System to Circumvent Hepatic Metabolism for Oral Delivery of Lipid-Based Nanocarriers. J Drug Deliv Sci Technol 2021, 66, 102934. DOI: 10.1016/j.jddst.2021.102934.
   Web of Science ®Google Scholar
• Tahir, N.; Madni, A.; Correia, A.; Rehman, M.; Balasubramanian, V.; Khan, M. M.; Santos, H. A. Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy. Int J Nanomedicine 2019, 14, 4961–4974. DOI: 10.2147/IJN.S209325.
   PubMed Web of Science ®Google Scholar
• Mukherjee, A.; Waters, A. K.; Kalyan, P.; Achrol, A. S.; Kesari, S.; Yenugonda, V. M. Lipid–Polymer Hybrid Nanoparticles as a Next-Generation Drug Delivery Platform: state of the Art, Emerging Technologies, and Perspectives. Int J Nanomedicine 2019, 14, 1937–1952. DOI: 10.2147/IJN.S198353.
   PubMed Web of Science ®Google Scholar
• Ramasamy, T.; Tran, T. H.; Choi, J. Y.; Cho, H. J.; Kim, J. H.; Yong, C. S.; Choi, H.-G.; Kim, J. O. Layer-by-Layer Coated Lipid-Polymer Hybrid Nanoparticles Designed for Use in Anticancer Drug Delivery. Carbohydr Polym 2014, 102, 653–661. DOI: 10.1016/j.carbpol.2013.11.009.
   PubMed Web of Science ®Google Scholar
• Gurumukhi, V. C.; Bari, S. B. Development of Ritonavir-Loaded Nanostructured Lipid Carriers Employing Quality by Design (QbD) as a Tool: characterizations, Permeability, and Bioavailability Studies. Drug Deliv Transl Res 2022, 12, 1753–1773. DOI: 10.1007/s13346-021-01083-5.
   PubMed Web of Science ®Google Scholar
• Ana, R.; Mendes, M.; Sousa, J.; Pais, A.; Falcão, A.; Fortuna, A.; Vitorino, C. Rethinking Carbamazepine Oral Delivery Using Polymer-Lipid Hybrid Nanoparticles. Int J Pharm 2019, 554, 352–365. DOI: 10.1016/j.ijpharm.2018.11.028.
   PubMed Web of Science ®Google Scholar
• Heredia, N. S.; Vizuete, K.; Flores-Calero, M.; Pazmiño V, K.; Pilaquinga, F.; Kumar, B.; Debut, A. Comparative Statistical Analysis of the Release Kinetics Models for Nanoprecipitated Drug Delivery Systems Based on Poly(Lactic-co-Glycolic Acid). PLoS One 2022, 17, e0264825. DOI: 10.1371/journal.pone.0264825.
   PubMed Web of Science ®Google Scholar
• Shelton, K. L.; Hendrick, E. S.; Beardsley, P. M. Efficacy of Buspirone for Attenuating Cocaine and Methamphetamine Reinstatement in Rats. Drug Alcohol Depend 2013, 129, 210–216. DOI: 10.1016/j.drugalcdep.2013.01.003.
   PubMed Web of Science ®Google Scholar
• Basaveswara Rao, M. V.; Nagendrakumar, A. V. D.; Maiti, S.; Raja, G. Validated RP-HPLC Method for the Determination of Buspirone in Pharmaceutical Formulations. Chromatography Research International 2011, 2011, 1–3. DOI: 10.4061/2011/232505.
   Google Scholar
• Kim, K. T.; Lee, J.-Y.; Park, J.-H.; Kim, M. H.; Kim, J.-S.; Shin, H.-J.; Kang, N.; Cho, H.-J.; Yoon, I.-S.; Kim, D.-D. Development of HPLC Method for the Determination of Buspirone in Rat Plasma Using Fluorescence Detection and Its Application to a Pharmacokinetic Study. Chem Pharm Bull) 2016, 64, 1582–1588. DOI: 10.1248/cpb.c16-00405.
   PubMed Web of Science ®Google Scholar
• Gurumukhi, V. C.; Bari, S. B. Fabrication of Efavirenz Loaded Nano-Formulation Using Quality by Design (QbD) Based Approach: Exploring Characterizations and in Vivo Safety. J Drug Deliv Sci Technol 2020, 56, 101545. DOI: 10.1016/j.jddst.2020.101545.
   Web of Science ®Google Scholar
• Dangre, P. V.; Tattu, A. D.; Borikar, S. P.; Surana, S. J.; Chalikwar, S. S. Development and Statistical Optimization of alginate-Neusilin US2 Micro-Composite Beads to Elicit Gastric Stability and Sustained Action of Hesperidin. Int J Biol Macromol 2021, 171, 514–526. DOI: 10.1016/j.ijbiomac.2021.01.025.
   PubMed Web of Science ®Google Scholar
• Dangre, P. V.; Dusad, P. P.; Singh, A. D.; Surana, S. J.; Chaturvedi, K. K.; Chalikwar, S. S. Fabrication of Hesperidin Self-Micro-Emulsifying Nutraceutical Delivery System Embedded in Sodium Alginate Beads to Elicit Gastric Stability. Polym. Bull 2022, 79, 605–626. DOI: 10.1007/s00289-020-03507-7.
   Web of Science ®Google Scholar
• Alkhatib, H. S.; Aiedeh, K. M.; Bustanji, Y.; Hamed, S.; Mohammad, M. K.; Alkhalidi, B.; Najjar, S. Modulation of Buspirone HCl Release from Hypromellose Matrices Using Chitosan Succinate: Implications for pH-Independent Release. Eur J Pharm Biopharm 2008, 70, 804–812. DOI: 10.1016/j.ejpb.2008.06.017.
   PubMed Web of Science ®Google Scholar
• Pardeshi, C. V.; Belgamwar, V. S. Ropinirole-Dextran Sulfate Nanoplex for Nasal Administration against Parkinson’s Disease: In Silico Molecular Modeling and in Vitro–Ex Vivo Evaluation. Artif Cells Nanomed Biotechnol 2017, 45, 635–648. DOI: 10.3109/21691401.2016.1167703.
   PubMed Web of Science ®Google Scholar
• Nguyen, V. H.; Thuy, V. N.; Van, T. V.; Dao, A. H.; Lee, B.-J. Nanostructured Lipid Carriers and Their Potential Applications for Versatile Drug Delivery via Oral Administration. OpenNano 2022, 8, 100064. DOI: 10.1016/j.onano.2022.100064.
   Google Scholar
• Remya, P.; N; Damodharan, N. Formulation, Development, and Characterisation of Cilnidipine Loaded Solid Lipid Nanoparticles. Asian J Pharm Clin Res 2018, 11, 120–125. DOI: 10.22159/ajpcr.2018.v11i9.24666.
   Google Scholar
• Khan, M. M.; Madni, A.; Torchilin, V.; Filipczak, N.; Pan, J.; Tahir, N.; Shah, H. Lipid-Chitosan Hybrid Nanoparticles for Controlled Delivery of Cisplatin. Drug Deliv 2019, 26, 765–772. DOI: 10.1080/10717544.2019.1642420.
   PubMed Web of Science ®Google Scholar
• Dangre, P. V.; Shinde, S. B.; Surana, S. J.; Jain, P. G.; Chalikwar, S. S. Development and Exploration on Flowability of Solid Self-Nanoemulsifying Drug Delivery System of Morin Hydrate. Adv Powder Technol 2022, 33, 103716. DOI: 10.1016/j.apt.2022.103716.
   Web of Science ®Google Scholar
• Diwan, R.; Ravi, P.; R; Pathare, N. S.; Aggarwal, V. Pharmacodynamic, Pharmacokinetic and Physical Characterization of Cilnidipine Loaded Solid Lipid Nanoparticles for Oral Delivery Optimized Using the Principles of Design of Experiments. Colloids Surf B Biointerfaces 2020, 193, 111073. DOI: 10.1016/j.colsurfb.2020.111073.
   PubMed Web of Science ®Google Scholar
• Du, M.; Ouyang, Y.; Meng, F.; Zhang, X.; Ma, Q.; Zhuang, Y.; Liu, H.; Pang, M.; Cai, T.; Cai, Y. Polymer-Lipid Hybrid Nanoparticles: A Novel Drug Delivery System for Enhancing the Activity of Psoralen against Breast Cancer. Int J Pharm 2019, 561, 274–282. DOI: 10.1016/j.ijpharm.2019.03.006.
   PubMed Web of Science ®Google Scholar
• Dave, V.; Yadav, R. B.; Kushwaha, K.; Yadav, S.; Sharma, S.; Agrawal, U. Lipid-Polymer Hybrid Nanoparticles: Development & Statistical Optimization of Norfloxacin for Topical Drug Delivery System. Bioact Mater 2017, 2, 269–280. DOI: 10.1016/j.bioactmat.2017.07.002.
   PubMed Web of Science ®Google Scholar